Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Incretin Mimetic Drugs


Here is a list of incretin mimetic drugs, their FDA-approved usage / indications, and the side effects that we are currently investigating:

Saxenda / Byetta / Bydureon / Victoza / Januvia / Janumet (XR) / Juvisync / Onglyza / Kombiglyze XR / Nesina / Kazano / Oseni / Tradjenta / Jentadueto


Prescribed/Used for:

Weight management for patients with a BMI of 27 or greater
  • Saxenda (liraglutide)
Treatment of type 2 diabetes mellitus (improve glycemic control)
  • Byetta (exenatide)
  • Bydureon (exenatide)
  • Victoza (liraglutide)
  • Januvia (sitagliptin)
  • Janumet (sitagliptin)
  • Janumet XR (sitagliptin)
  • Juvisync (sitagliptin)
  • Onglyza (saxagliptin)
  • Kombiglyze XR (saxagliptin)
  • Nesina (alogliptin)
  • Kazano (alogliptin)
  • Oseni (alogliptin)
  • Tradjenta (linagliptin)
  • Jentadueto (linagliptin)

Side Effects We Are Investigating:

Pancreatic / Pancreas Cancer


Recent articles by attorney Tom Lamb on the Drug Injury Law web site:

  • Certain Diabetes Drugs Like Januvia Associated With Bile Duct Cancer
  • Current Number Of Lawsuits Filed In Diabetes Drugs Federal Court MDL Cases
  • Pancreatic Cancer Lawsuits Reinstated for Incretin-Based Diabetes Drugs
  • Diabetes Drugs Bydureon And Victoza: Thyroid Cancer Label Change In March 2015 Comes Without Much Notice
  • Pancreatic Cancer As A Side Effect Of Diabetes Drugs Bydureon, Byetta, Januvia, And Victoza
  • Byetta / Januvia / Victoza: Update On Possible Association Between These Newer Diabetes Drugs And Pancreatic Cancer As A Side Effect
  • Cancer of The Pancreas: Possible Side Effect For Diabetics Who Use Byetta, Januvia, Or Victoza?
  • Emerging Drug Safety Issue: Possible Increased Risk Of Pancreatic Cancer With Byetta, Januvia, And Victoza — Little Is Known About Long-Term Effects
  • Byetta And Januvia: More Debate About The Possible Increased Risk Of Pancreatitis, Pancreatic Cancer, And Thyroid Cancer
  • Gastroenterology Medical Journal Withdraws Januvia / Byetta Article Due To Letters From Drug Companies
  • FDA Wants Studies Done On Byetta Safety, With Focus On Pancreatitis, Pancreatic Cancer, Thyroid Neoplasm, And Acute Renal Failure

Go to Drug Injury / Death Case Evaluation for Saxenda or Incretin Mimetic diabetes drugs

Go to Drug Injury Law for more information on Saxenda or Incretin Mimetic diabetes drugs

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.